Status:
UNKNOWN
Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Lynch Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
Colorectal cancer (CRC) is the second cause of cancer-related death in western countries. CRC prevention and screening are major public health issues. Better knowledge of colorectal carcinogenesis cou...
Detailed Description
Background and originality of the project with regards to the state of the art : Colorectal cancer (CRC) is the second leading cause of cancer-related death in western countries and the third most pr...
Eligibility Criteria
Inclusion
- Patients included in the AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
- Fecal samples taken for the AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
- Food questionnaires collected as part of the AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
Exclusion
- Patients who did not included in the AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
- Patients who did not consent for the Fecal samples in AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
- Patients who did not do the Food questionnairy in AAS-Lynch study (NCT02813824 on clinicaltrials.gov)
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT04791644
Start Date
April 20 2021
End Date
December 30 2024
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Avicenne, AP-HP, Service de Gastroentérologie et Oncologie Digestive
Bobigny, Paris/Seine-Saint-Denis, France, 93000